Proteomics of Aqueous Humor as a Source of Disease Biomarkers in Retinoblastoma

Angela Galardi, Christina Stathopoulos, Marta Colletti, Chiara Lavarello, Ida Russo, Raffaele Cozza, Antonino Romanzo, Angel M. Carcaboso, Franco Locatelli, Andrea Petretto, Francis L. Munier, Angela Di Giannatale

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Aqueous humor (AH) can be easily and safely used to evaluate disease-specific biomarkers in ocular disease. The aim of this study was to identify specific proteins biomarkers in the AH of retinoblastoma (RB) patients at various stages of the disease. We analyzed the proteome of 53 AH samples using high-resolution mass spectrometry. We grouped the samples according to active vitreous seeding (Group 1), active aqueous seeding (Group 2), naive RB (group 3), inactive RB (group 4), and congenital cataracts as the control (Group 5). We found a total of 889 proteins in all samples. Comparative parametric analyses among the different groups revealed three additional proteins expressed in the RB groups that were not expressed in the control group. These were histone H2B type 2-E (HISTH2B2E), InaD-like protein (PATJ), and ubiquitin conjugating enzyme E2 V1 (UBE2V1). Upon processing the data of our study with the OpenTarget Tool software, we found that glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and CD44 were more highly expressed in the RB groups. Our results provide a proteome database regarding AH related to RB disease that may be used as a source of biomarkers. Further prospective studies should validate our finding in a large cohort of RB patients.
Lingua originaleEnglish
pagine (da-a)1-14
Numero di pagine14
RivistaInternational Journal of Molecular Sciences
Volume23
DOI
Stato di pubblicazionePubblicato - 2022

Keywords

  • aqueous humor
  • tumor biomarker
  • retinoblastoma
  • proteomic

Fingerprint

Entra nei temi di ricerca di 'Proteomics of Aqueous Humor as a Source of Disease Biomarkers in Retinoblastoma'. Insieme formano una fingerprint unica.

Cita questo